The upregulation of NHERF1 has been reported in multiple disease states, including hepatocellular carcinomas, cholangiopathies, glioblastoma, breast cancer, psoriasis, and vascular injury [50,51,52,53,54,55,56]. Here, NHERF1 is linked to breast cancer.